ImmunoGen
-$0.07 (-1.98%) Today
$0.00 (0.00%) As of 9:59 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunoGen and other ETFs, options, and stocks.
About IMGN
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151.
CEO
Mark Joseph Enyedy
Employees
106
Headquarters
Waltham, Massachusetts
Founded
1981
IMGN Key Statistics
Market cap
765.26M
Price-Earnings ratio
—
Dividend yield
—
Average volume
5.57M
High today
$3.63
Low today
$3.36
Open price
$3.53
Volume
3.26M
52 Week high
$7.77
52 Week low
$3.36
IMGN News
Analyst ratings
70%
of 10 ratings
Buy
70%
Hold
30%
Sell
0%
IMGN Earnings
-$1.71
-$1.09
-$0.46
$0.16
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 29, Pre-Market